{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-162537","form_type":"8-K","ticker":null,"cik":"0001463361","company_name":"Unity Biotechnology, Inc.","filed_at":"2025-07-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.035216+00:00","generated_at":"2026-05-18T04:15:33.693339+00:00","sec_items":["1.01","5.03","3.02","3.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Unity Biotechnology issues Series A Preferred with 600M votes to facilitate dissolution approval","bullets":["Issued one Series A Preferred share to sole director Craig R. Jalbert for $1.00; share carries 600M votes, only on dissolution proposal.","Series A votes in same proportion as common votes cast, excluding abstentions and broker non-votes, neutralizing their effect.","Prior to issuance, dissolution required majority of outstanding common; now requires majority of voting power (common + Series A) with proportional voting.","Series A automatically transfers back to company for no consideration upon stockholder approval of dissolution.","Company delisted from Nasdaq on July 9, 2025; now trades OTC Pink under UNBX."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-162537","json":"https://secwatch.observer/filing/0001193125-25-162537.json","markdown":"https://secwatch.observer/filing/0001193125-25-162537.md","text":"https://secwatch.observer/filing/0001193125-25-162537.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1463361/000119312525162537/0001193125-25-162537-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1463361/000119312525162537/d921163d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T04:15:33.693339+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"026d875a617cfecfc8e086923a254044df710ce6","claim":"Unity Biotechnology, Inc.: Filed Certificate of Designation establishing Series A Preferred Stock with voting, dividend, liquidation, and transfer restrictions (effective 2025-07-21).","evidence_excerpt":"On July 21, 2025, the Company filed the Certificate of Designation of Series A Preferred Stock with the Secretary of State of the State of Delaware, which sets forth the rights, preferences and privileges of the Series A Preferred Share.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1463361/000119312525162537/0001193125-25-162537-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-07-21"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}